Postmenopozal Osteoporozlu Kadinlarda Kinezyofobinin Yaşam Kalitesi Üzerine Etkisi

Yıl 2020, Cilt: 15 Sayı: 3, 40 - 46, 16.10.2020

Türkan Turgay , Pinar Gunel Karadeniz

https://doi.org/10.17517/ksutfd.719089

Cited By: 2

Öz

Amaç: Bu çalışmada postmenopozal osteoporozlu kadınlarda kinezyofobinin yaşam kalitesi üzerine etkisinin araştırılması amaçlanmıştır.
Gereç ve Yöntemler: Bu çalışmaya Fiziksel Tıp ve Rehabilitasyon polikliniğine başvuran ve 50 yaş ve üzeri postmenpozal osteoporoz tanısı alan 70 kadın hasta ve 69 kadın kontrol dahil edildi. Yaş, vücut kilo indeksi (VKİ), lomber vertebral L1-L4 kemik mineral yoğunluğu (LVKMY), femur boyun kemik mineral yoğunluğu (FBKMY) T-skoru değerleri ve geçirilmiş kırık varlığı kaydedildi. Katılımcıların sırt ağrısı Görsel Analog Skala (GAS) (0-10 cm) ile değerlendirildi. Yaşam kalitesi değerlendirmesi için QUALEFFO-41 (Quality of Life Questionnaire of the European Foundation for Osteoporosis) ölçeği ve kinezyofobi değerlendirmesi için Tampa Kinezyofobi Ölçeği (TKÖ) kullanıldı.
Bulgular: Çalışmaya katılan 70 osteoporozlu ve 69 kontrol grubu hastanın yaş ortalamaları sırasıyla; 69.86±9.43, 65.39±8.42 idi (p<0.001). Osteoporotik grup ile osteoporotik olmayan grup arasında LVKMY, FBKMY, GAS-sırt ağrısı, QUALEFFO-41 total skor ve TKÖ skoru açısından istatistiksel olarak anlamlı farklılık bulunmuştur (p<0.001). QUALEFFO-41’in alt grup ölçekleri değerlendirildiğinde; genel sağlık durumu değerlendirmesi (p=0.71) dışındaki diğer ağrı, fiziksel fonksiyon, boş zaman ve sosyal aktiviteler, mental fonksiyon parametrelerinde iki grup arasında anlamlı bir fark bulunmuştur (p<0.05). Osteoporoz grubunda QUALEFFO-41 toplam skoru ile kinezyofobi skoru arasında anlamlı bir korelasyon bulunmuştur (r=0.618, p<0.001). Ayrıca, TKÖ ile yaş ve FBKMY arasında anlamlı korelasyon bulunmuştur (sırasıyla; r=0.621, p<0.00; r=-0.477, p<0.001).
Sonuç: Çalışmamızda osteoporoz hastalarında ileri yaş ve düşük FBKMY değerlerinin kinezyofobiyi arttırarak yaşam kalitesini azalttığı gösterilmiştir.

Anahtar Kelimeler

Kinezyofobi, Osteoporoz, Yaşam kalitesi

The Effect of Kinesiophobia on Quality of Life in Women with Postmenopausal Osteoporosis

Öz

Objective: In this study, it was aimed to investigate the effect of kinesiophobia on quality of life in women with postmenopausal osteoporosis.
Material and methods: This study included 70 females who were admitted to the Physical Medicine and Rehabilitation outpatient clinic and were diagnosed with postmenopausal osteoporosis aged 50 and over, and 69 female controls. Age, body weight index (BMI), lumbar vertebral L1-L4 bone mineral density (LVBMD), femoral neck bone mineral density (FNBMD) T-score values and history of fracture were recorded. Back pain of the participants was evaluated via Visual Analogue Scale (VAS) (0-10 cm). QUALEFFO-41 (Quality of Life Questionnaire of the European Foundation for Osteoporosis) scale was used for quality of life assessment and Tampa Kinesiophobia Scale (TKS) was used for assessment of kinesiophobia.
Results: The average age of 70 patients with osteoporosis and 69 control who were included in the study was 69.86±9.43, 65.39±8.42, respectively (p<0.001). A statistically significant difference was found between the osteoporotic and the non-osteoporotic group in terms of LVBMD, FNBMD, VAS-back pain, QUALEFFO-41 total score and TKS score (p<0.001). When subgroup scales of QUALEFFO-41 was evaluated, a significant difference was found between the two groups in the parameters of pain, physical function, leisure time and social activities, mental function (p<0.05), except general health status (p=0.71). A significant correlation was found between QUALEFFO-41 total score and kinesiophobia score in the osteoporosis group (r=0.618, p<0.001) also between TKS and age and FNBMD (r=0.621, p<0.00, r=-0.477, p<0.001, respectively).
Conclusion: In our study, it has been revealed that high age and low FNBMD values in osteoporosis patients decrease the quality of life by increasing kinesiophobia.

Anahtar Kelimeler

Kinesiophobia, Osteoporosis, Quality of life

Kaynakça

• Referans1. http://www.iofbonehealth.org
• Referans2. Tuzun S, Eskiyurt N, Akarirmak U, Saridogan M, Senocak M, Johansson H, et al. Turkish Osteoporosis Society. Incidence of hip fracture and prevalence of osteoporosis in Turkey: the FRACTURK study. Osteoporos Int. 2012;23:949–55.
• Referans3. Chew CK, Clarke BL. Causes of low peak bone mass in women. Maturitas. 2018;111(5):61-68.
• Referans4. Oleksik A, Lips P, Dawson A, Minshall ME, Shen W, Cooper C, et al. Health-related quality of life in postmenopausal women with low BMD with or without prevalent vertebral fractures. J Bone Miner Res. 2000;15: 1384–92.
• Referans5. Mohd-Tahir NA, Li SC. Economic burden of osteoporosis-related hip fracture in Asia: a systematic review. Osteoporos Int. 2017;28:2035–44.
• Referans6. Larsson C, Ekvall Hansson E, Sundquist K, Jakobsson U. Impact of pain characteristics and fear-avoidance beliefs on physical activity levels among older adults with chronic pain: a population-based, longitudinal study. BMC Geriatr. 2016;16:50.
• Referans7. Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56: 146-157.
• Referans8. Gunendi Z, Eker D, Tecer D, Karaoglan B, Ozyemisci Tas Kıran O. Is the word “osteoporosis” a reason for kinesiophobia? Eur J Phys Rehab Med. 2018;54(5):671-5.
• Referans9. Kanis JA, McCloskey EV, Johansson H, Cooper C, Rizzoli R, Reginster JY; Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the Committee of Scientific Advisors of the International Osteoporosis Foundation (IOF). European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int.2013;24:23–57.
• Referans10. World Health Organization. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO study group. Geneva, World Health Organization, 1994 (WHO Technical Report Series, No. 843).
• Referans11. Hawker GA, Mian S, Kendzerska T, French M. Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF-36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP). Arthritis Care Res (Hoboken). 2011;63(11):240-52. Referans12. Kocyigit H, Gulseren S, Erol A, Hızlı N, Memis A. The reliability and validity of the Turkish version of Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO). Clin Rheumatol. 2003;22(1):18-23.
• Referans13. Tunca Yılmaz O, Yakut Y, Uygur F, Ulug N. Tampa Kinezyofobi Ölçeği’nin Türkçe versiyonu ve test-tekrar test güvenirliği. Turkish version of the Tampa Scale for Kinesiophobia and its test-retest reliability. Fizyoter Rehabil. 2011;22(1):44-49.
• Referans14. Gregg CD, McIntosh G, Hall H, Watson H, Williams D, Hoffman CW. The relationship between the Tampa Scale of Kinesiophobia and low back pain rehabilitation outcomes. The Spine Journal: Official Journal of the North American Spine Society. 2015;15(12):2466-2471.
• Referans15. Koho P, Aho S, Watson P, Hurri H. Assessment of chronic pain behaviour: reliability of the method and its relationship with perceived disability, physical impairment and function. J Rehabil Med. 2001;33:128/132.
• Referans16. Swinkels-Meewisse IE, Roelofs J, Verbeek AL, Oostendorp RA, Vlaeyen JW. Fear of movement/(re)injury, disability and participation in acute low back pain. Pain. 2003; 105:371-379.
• Referans17. Fishbain DA, Cole B, Lewis JE, Gao J. Antidepressant Depression Treatment Response and Remission in Patients with Depression and Pain? An Evidence-Based Structured Review. Pain Med. 2014 Sep;15(9):1522-39.
• Referans18. Knapik A, Saulicz E, Gnat R. Kinesiophobia introducing a new diagnostic tool. J hum Kinet. 2011;28:25–31.
• Referans19. Gunendi Z, Eker D, Tecer D, Karaoglan B, Ozyemisci-Taskiran O. Is the word "osteoporosis" a reason for kinesiophobia? Eur J Phys Rehabil Med. 2018 Oct;54(5):671-675.
• Referans20. Pereira LS, Sherrington C, Ferreira ML, Tiedemann A, Ferreira PH, Blyth FM, et al. Self-reported chronic pain is associated with physical performance in older people leaving aged care rehabilitation. Clin Interv Aging. 2014;14(9):259-65.
• Referans21. Jarvinen TL, Sievanen H, Khan KM, et al: Shifting the focus in fracture prevention osteoporosis to falls. BMJ. 2008; 336:124-126.
• Referans22. Gold DT. The nonskeletal consequences of osteoporotic fractures. Psychologic and social outcomes. Rheum Dis Clin North Am. 2001;27: 255–62.
• Referans23. Lindsay R. Pathogenesis, detection and prevention of postmenopausal osteoporosis. In: Studd J, Whitehead M, eds. The menopause. Oxford: Blackwell Scientific Publications. 1988;156–67.
• Referans24. Kanis JA, Minne HW, Meunier PJ et al. Quality of life and vertebral osteoporosis. Osteoporosis Int. 1992;2: 161–3.
• Referans25. Nur H, Toraman NF. Postmenopozal osteoporozda vertebral kırıkların yaşam kalitesine etkisi. Turk J Osteoporos. 2011;17:81-4.
• Referans26. Başaran S, Güzel R, Benlidayı İC, Uysal FG. Postmenopozal ve senil osteoporozlu kadınlarda yaşam kalitesinin ve belirleyicilerinin değerlendirilmesi. Turk J Phys Med Rehab. 2006;52:31-6.
• Referans27. Oksuz s, Unal E. The effect of the clinical pilates exercises on kinesiophobia and other symptoms related to osteoporosis: Randomised controlled trial. Complement Ther Clin Pract. 2017;26:68–72.
• Referans28. Gianoudis J, Bailey CA, Ebeling PR, Nowson CA, Sanders KM, Hill K, et al. Effects of a targeted multimodal exercise program incorporating high-speed power training on falls and fracture risk factors in older adults: a community based randomized controlled trial. J Bone Miner Res. 2014;29:182–91.
• Referans29. Aveiro MC, Avila MA, Pereira-Baldon VS, Ceccatto Oliveira ASB, Gramani-Say K, Oishi J, et al. Water versus land-based treatment for postural control in postmenopausal osteoporotic women: a randomized, controlled trial. Climacteric. 2017;20:427–35.